deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT04537429

A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

An Open-label, Single-dose, Pharmacokinetic Study to Evaluate IV Eptinezumab in Children and Adolescents With Migraine, Followed by an Optional, Multiple-dose, Open-label Extension Period

Sponsor: H. Lundbeck A/S

Conditions Migraine Migraine in Children
Interventions Eptinezumab
Updated 13 times since 2020 Last updated: Oct 5, 2023 Started: Aug 4, 2020 Primary completion: Oct 20, 2022 Completion: Aug 21, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Migraine and Migraine in Children, this trial is completed. The trial is conducted by H. Lundbeck A/S and has accumulated 13 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~May 2023 · 5 months · monthly snapshot~May 2023 – ~Nov 2023 · 6 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2023 — Jul 2024 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

  4. May 2023 — Nov 2023 [monthly]

    Active Not Recruiting PHASE1

  5. Dec 2022 — May 2023 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

▶ Show 8 earlier versions

  1. Sep 2022 — Dec 2022 [monthly]

    Recruiting PHASE1

  2. Dec 2021 — Sep 2022 [monthly]

    Recruiting PHASE1

  3. Oct 2021 — Dec 2021 [monthly]

    Recruiting PHASE1

  4. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE1

  5. Feb 2021 — Sep 2021 [monthly]

    Recruiting PHASE1

  6. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1

  7. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  8. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

    First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lundbeck A/S
Data source: H. Lundbeck A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations